Adverse events with bismuth salts for Helicobacter pylori eradication: systematic review and meta-analysis.
about
Optimum duration of regimens for Helicobacter pylori eradicationReview article: bismuth-based therapy for Helicobacter pylori eradication in childrenCurrent Helicobacter pylori treatment in 2014Novel and Effective Therapeutic Regimens for Helicobacter pylori in an Era of Increasing Antibiotic Resistance.Failure or success of electronic search strategies to identify adverse effects data.Treatment of Helicobacter pylori infection: Past, present and futureEfficacy and safety of ecabet sodium as an adjuvant therapy for Helicobacter pylori eradication: a systematic review and meta-analysis.Modified sequential therapy vs quadruple therapy as initial therapy in patients with Helicobacter infection.Comparison of Second-Line Quadruple Therapies with or without Bismuth for Helicobacter pylori InfectionThe challenge of Helicobacter pylori resistance to antibiotics: the comeback of bismuth-based quadruple therapy.Pharmacological regimens for eradication of Helicobacter pylori: an overview of systematic reviews and network meta-analysis.Quadruple therapy with moxifloxacin and bismuth for first-line treatment of Helicobacter pylori.Comparison of three different regimens against Helicobacter pylori as a first-line treatment: A randomized clinical trialEfficacy of Proton Pump Inhibitor-based Triple Therapy and Bismuth-based Quadruple Therapy for Helicobacter pylori Eradication in Korean Children.Pylera for the eradication of Helicobacter pylori infection.Second-line bismuth-containing quadruple therapy for Helicobacter pylori eradication and impact of diabetesCurrent pharmacotherapy options for gastritis.Fourth Chinese National Consensus Report on the management of Helicobacter pylori infection.Treatment of Helicobacter pylori infection: meeting the challenge of antimicrobial resistance.Review: efficacy and safety of hybrid therapy for Helicobacter pylori infection: a systematic review and meta-analysis.Review: clinical management of Helicobacter pylori infection in China.How to Effectively Use Bismuth Quadruple Therapy: The Good, the Bad, and the Ugly.Optimization strategies aimed to increase the efficacy of H. pylori eradication therapies.Efficacy of three-in-one capsule bismuth quadruple therapy for Helicobacter pylori eradication in clinical practice in a multinational patient population.Rifabutin Containing Triple Therapy and Rifabutin with Bismuth Containing Quadruple Therapy for Third-Line Treatment of Helicobacter pylori Infection: Two Pilot Studies.Helicobacter pylori second-line rescue therapy with levofloxacin- and bismuth-containing quadruple therapy, after failure of standard triple or non-bismuth quadruple treatments.The performance of adverse effects search filters in MEDLINE and EMBASE.Use of a combination formulation of bismuth, metronidazole and tetracycline with omeprazole as a rescue therapy for eradication of Helicobacter pylori.Treatment of Helicobacter pylori infection in atrophic gastritis.Efficacy and Tolerability of Two Quadruple Regimens: Bismuth, Omeprazole, Metronidazole with Amoxicillin or Tetracycline as First-Line Treatment for Eradication of Helicobacter Pylori in Patients with Duodenal Ulcer: A Randomized Clinical Trial.
P2860
Q24201841-41C33751-851C-4898-B5DF-BCE5A97F087BQ26998597-AA41C407-5161-4A5B-9C27-1A841FB41378Q27000209-1466A0AC-765F-4DAB-B210-D8F38DAC0FEFQ33639114-24B1F285-9D59-403C-A542-E009A73D2DBEQ34238325-5B015232-8349-4509-A1D0-70BE9B2590EEQ34508830-EF7C8A19-B6B0-445D-B01B-02AC23799B1CQ35168327-4500DBF6-886B-4C5C-89D5-E4ABDAD66ADCQ35651560-36832D92-854B-4E8F-A13C-FA2666B6C163Q35668797-4AF26182-8EB8-4202-8A39-28921AA425D0Q35810200-6F38B602-9073-406A-A268-16C7A16DBDF1Q36086382-F3487AC0-B70E-4CB7-8544-841C5360AC51Q36215547-47171C79-F472-4710-8E19-91CDB46E502EQ36614237-0231D6CA-2211-47E1-8DEF-A080805E3865Q37101539-522F61DB-9FF8-4B0C-9159-A7E81A56225BQ37593096-7CC02804-644F-4097-A6A2-D2DF15CF60D8Q37643990-02A74562-D878-44DC-8061-AFB17B73F4B3Q38061147-52EE402B-8C82-4E84-9E19-34B2FFD8AC6EQ38072783-F047BC8A-6AB9-4A0E-9114-5B651BC111C8Q38238745-39BC1669-08E9-4791-9A61-2C6C34139717Q38266303-5E29029D-2F0E-4910-B6DB-AB072B43672DQ38266432-99EB2A5E-128E-4AAD-B175-C902DB0D8204Q38575216-8996121E-018A-4981-A310-AA101F121303Q39278632-D08A98CD-7742-4842-A0FA-70A3EBBD7699Q40082686-DBF294B5-3EA9-4640-99FE-5D2B81246F4DQ40819420-56060427-BA9A-4C35-9224-7F7BA22D4973Q41471323-4154C6CC-31D0-44A6-82A2-389BE022003EQ44546996-319DDC9D-3A68-4EA2-8334-771F8BD5DDB3Q51721357-4BA6A7A3-2A5C-43D1-9656-0DBAD46B239CQ55154581-FF9B54C2-78B9-4C34-AE7E-5B98D948F960Q55280909-8B5E2719-D1CE-4582-9E1E-8CE037A5EFE4
P2860
Adverse events with bismuth salts for Helicobacter pylori eradication: systematic review and meta-analysis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Adverse events with bismuth sa ...... atic review and meta-analysis.
@en
Adverse events with bismuth sa ...... atic review and meta-analysis.
@en-gb
Adverse events with bismuth sa ...... atic review and meta-analysis.
@nl
type
label
Adverse events with bismuth sa ...... atic review and meta-analysis.
@en
Adverse events with bismuth sa ...... atic review and meta-analysis.
@en-gb
Adverse events with bismuth sa ...... atic review and meta-analysis.
@nl
prefLabel
Adverse events with bismuth sa ...... atic review and meta-analysis.
@en
Adverse events with bismuth sa ...... atic review and meta-analysis.
@en-gb
Adverse events with bismuth sa ...... atic review and meta-analysis.
@nl
P2093
P2860
P50
P356
P1476
Adverse events with bismuth sa ...... atic review and meta-analysis.
@en
P2093
Jose Santana
Monique Giguere
Mostafizur Khan
P2860
P304
P356
10.3748/WJG.14.7361
P407
P577
2008-12-01T00:00:00Z